Exploring treatment options in cancer: tumor treatment strategies
Ineligibility, Limitations To PR Uptake In Patients With AECOPD
Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Two posters presented at the CHEST 2024 annual meeting last week in Boston, Massachusetts, revealed that only 18% of eligible patients hospitalized with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) participated in pulmonary rehabilitation (PR) post-discharge, with ineligibility significantly limiting participation.
Only 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.Image Credit: peterschreiber.Media - stock.Adobe.Com
Education Needed to Boost Post-Discharge PR Enrollment in Patients With AECOPDThe first poster emphasized that health care providers and patients should be properly educated on PR referral and participation to ensure appropriate post-hospitalization care for those with AECOPD.1
The American Thoracic Society's 2023 guidelines recommended that patients participate in PR within 3 weeks of admission for AECOPD.2 Despite this, previous research found that only 1.9% participated in PR within 6 months of their index hospitalization.3
Consequently, the researchers conducted a quality improvement initiative to assess current trends in PR enrollment after AECOPD hospitalization at Baystate Medical Center, a tertiary medical center in Springfield, Massachusetts.1 They aimed to improve PR uptake by understanding barriers to referral and participation.
The researchers conducted a retrospective analysis of patients admitted with AECOPD between December 1, 2022, and December 1, 2023; they identified eligible patients using the International Classification of Diseases, 10th Revision (ICD-10) code J.441. Additionally, the researchers identified those evaluated at the Baystate Medical Center pulmonary rehab facilities using the Current Procedural Terminology (CPT) code 94625.
Through this process, 1255 AECOPD encounters were identified, but 770 patients qualified for the final analysis. Of these patients, 140 (18%) were evaluated at the pulmonary rehab facilities. PR participants were older, with a mean (SD) age of 71.1 (8.6) years vs non-participants, who were 64.5 (10.7) years old.
Among both participants and non-participants, the hospital length of stay was highly variable, with a mean of 5.2 days. Additionally, the researchers found that only 3 patients hospitalized for over 7 days were seen at PR.
At discharge, 58% of the cohort required additional services. More specifically, 36.5% required visiting nurses and physical therapists, while 21% were discharged to nursing facilities. Lastly, the researchers emphasized that 197 patients had recurrent admissions within the study period, accounting for 46.4% of total AECOPD admissions; only 8 were evaluated at PR.
"...Emphasis on PR referral and enrollment in those with recurrent admissions or pronged hospital stays might lead to a decrease in the health care burden," the authors concluded. "More research is needed to elucidate barriers to referral and participation in PR."
Ineligibility Significantly Limits Post-Discharge PR UptakeBuilding on these findings, the second poster explored eligibility and ineligibility categories in PR post-discharge.4 Although multiple factors likely influence post-discharge PR participation, the researchers claimed that patient PR eligibility has received relatively little attention.
Therefore, 3 physician or advanced practice registered nurse (APRN) investigators with clinical pulmonary experience performed independent hospital data reviews of all patients discharged with codes indicating acute respiratory failure or a COPD exacerbation over 1 year, beginning on June 1, 2022; they performed the reviews at 2 hospitals, 1 in a suburban setting and the other in an urban setting.
The investigators made decisions regarding eligibility/ineligibility based only on medical record data and the interpretation of selection criteria from a joint American Thoracic Society and European Respiratory statement on PR.5 Therefore, patients were deemed potentially eligible for outpatient PR if 2 of the 3 reviewers agreed that a correct COPD diagnosis leading to hospitalization was made and the patient met all PR inclusion criteria and no exclusion criteria4; full concordance was considered if all 3 reviewers agreed.
The researchers identified 360 eligible patients, whose mean age was 71 (12) years. Most patients were female (53%) and White (76%); also, 40% were of lower socioeconomic status, meaning they had Medicaid or no insurance. Full concordance on patient PR eligibility/ineligibility was 73%.
Based on the agreement of 2 of 3 investigators, the reviewers considered only 38% of patients eligible for PR. The category that contributed most to ineligibility was having an illness or frailty either too great or putting the patient at excessive risk for participation (45%).
Another was having cognitive, psychiatric, or substance abuse issues that would preclude full PR participation (24%). Other categories that contributed to patient ineligibility were incorrect COPD diagnoses leading to hospitalization (19%), being institutionalized post-discharge (9%), and a language barrier (4%).
"Reported percentage uptake would likely increase if only eligible patients were analyzed," the authors concluded. "...A larger prospective study should be considered."
Overall, both posters underscore the significant underutilization of post-discharge PR among patients hospitalized with AECOPD and call for strategies to increase uptake by targeting eligibility criteria and participation barriers.
References
Interventional Pulmonology
Our interventional pulmonologists work with other expert providers at Huntsman Cancer Institute to treat people with cancers of the lung and chest wall, including rare cancers. They are part of a lung cancer team that includes thoracic surgeons, medical oncologists, radiation therapists, and others.
Our team of multidisciplinary lung cancer specialists is dedicated to your care and well-being. Together, we review each case, coordinate treatment, and plan follow-up care. Our team meets often to discuss your specific needs. We use the most advanced methods and innovative, state-of-the-art technology available to help you heal.
Baystate Health To Lay Off Managers: 5 Things To Know
Springfield, Mass.-based Baystate Health plans to lay off an unspecified number of managers by Thanksgiving, The Boston Globe reported Oct. 18.
Six things to know:
1. Baystate President and CEO Peter Banko told the Globe that the health system has been losing money and needs to lower costs. The system is expected to disclose the exact number of layoffs in two to three weeks.
2. The system lost $63 million in 2023 and $177 million in 2022, according to the report. Mr. Banko said the system would have lost $60 million in 2024 if it hadn't sold a lab to Labcorp for more than $133 million.
3. Mr. Banko said that the system's expenses have been growing faster than its revenue. More than 70% of its patients are Medicaid or Medicare beneficiaries, and Mr. Banko said neither government payer adequately reimburses Baystate for the cost of care.
4. The system is aiming to generate more than $225 million in savings and new revenue over the next two years. That plan includes cutting labor costs, but Mr. Banko said the system would not reduce patient services.
5. The Globe reported in September that three top executives would depart Baystate on Oct. 23. No explanation was shared for why the executives are leaving the health system. Those executives are Chief Information and Digital Officer Kevin Conway, Chief Human Resources Officer Kristin Morales-Lemieux and Chief Quality Officer Doug Salvador, MD.
6. Mr. Banko said in a statement shared with Becker's that last week the system announced "optimization of organizational and streamlined decision-making structures." This week, Baystate launched a system-wide strategic planning process that will " chart a new era of growth and expansion for the next five years."
"We are leaving no stone unturned in pursuit of corporate overhead, external spend, revenue cycle, clinical access and throughput, workforce management and strategic growth improvement levers," he said. "We are firmly committed to ensuring that our physicians, nurses and clinical teams have the support to deliver the high quality, safe care that Baystate is known for and our patients expect. Outside of implementing our new operating model, no other restructuring has been finalized."
Comments
Post a Comment